Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia

Gut and Liver

Volumn 7, Issue 2, 2013, Pages 228-233

  Kwak, Min Sun ^a   Jang, Eun Sun ^a   Ryu, Ji Kon ^a   Kim, Yong Tae ^a   Yoon, Yong Bum ^a   Park, Joo Kyung ^a  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Alkaline phospha tase; Bacteremia; Endoscopic retrograde biliary drainage; Endoscopic retrograde cholangiopancreatography; Liver transplantation

Indexed keywords

ALKALINE PHOSPHATASE; BETA LACTAMASE;

ADULT; AGE; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BACTEREMIA; BILIARY TRACT DRAINAGE; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MULTIVARIATE ANALYSIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY BACTEREMIA; PSEUDOMONAS INFECTION; RISK FACTOR; SEX;

EID: 84875107234     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2013.7.2.228     Document Type: Article

References (24)

1. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology 1976;70:314-320.
2. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918.
3. Deviere J, Motte S, Dumonceau JM, Serruys E, Thys JP, Cremer M. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy 1990;22:72-75.
4. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
5. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001;96:417-423.
6. Kullman E, Borch K, Lindström E, Anséhn S, Ihse I, Anderberg B. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc 1992;38:444-449.
7. Lam SK, Tsui JK, Chan PK, Wong KP, Ong GB. How often does bacteraemia occur following endoscopic retrograde cholangiopancreatography (ERCP)? Endoscopy 1977;9:231-234.
8. Leung JW, Ling TK, Chan RC, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994;40:716-721.
9. Anderson DJ, Shimpi RA, McDonald JR, et al. Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. Am J Infect Control 2008;36:592-594.
10. Ramirez FC, Osato MS, Graham DY, Woods KL. Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCP. J Dig Dis 2010;11:237-243.
11. James EC, Collin DB. Sepsis complications in endoscopic retrograde cholangiopancreatography. Am Surg 1976;42:229-232.
12. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991;101:1374-1381.
13. Hirschfield GM, Gibbs P, Griffiths WJ. Adult liver transplantation: what non-specialists need to know. BMJ 2009;338:b1670.
14. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003;75:1659-1663.
15. Sanna C, Saracco GM, Reggio D, et al. Endoscopic retrograde cholangiopancreatography in patients with biliary complications after orthotopic liver transplantation: outcomes and complications. Transplant Proc 2009;41:1319-1321.
16. Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994;219:40-45.
17. Thuluvath PJ, Pfau PR, Kimmey MB, Ginsberg GG. Biliary complications after liver transplantation: the role of endoscopy. Endoscopy 2005;37:857-863.
18. Calne RY. Immunosuppression in liver transplantation. N Engl J Med 1994;331:1154-1155.
19. Yabu JM, Vincenti F. Kidney transplantation: the ideal immunosuppression regimen. Adv Chronic Kidney Dis 2009;16:226-233.
20. Hashimoto M, Sugawara Y, Tamura S, et al. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults. Transpl Infect Dis 2009;11:11-19.
21. Iida T, Kaido T, Yagi S, et al. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 2010;16:1379-1385.
22. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992;37:689-696.
23. Melzer M, Toner R, Lacey S, Bettany E, Rait G. Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes. Postgrad Med J 2007;83:773-776.
24. Englesbe MJ, Dawes LG. Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB (Oxford) 2005;7:144-148